Thirteen related presentations from the Company at the Japanese Society for Neuroendovascular Therapy annual meeting
We are pleased to announce that thirteen AI-related presentations from the Company, including by our CEO Kono, were given at the 41st Annual Meeting of the Japanese Society for Neuroendovascular Therapy.
We are pleased to announce that thirteen AI-related presentations from the Company, including by our CEO Kono, were given at the 41st Annual Meeting of the Japanese Society for Neuroendovascular Therapy.
■About the 41st Annual Meeting of the Japanese Society for Neuroendovascular Therapy Held from November 11 to 15, 2025, it is the largest academic meeting in neuroendovascular therapy. Our CEO Kono presented at a symposium. Fri, Nov 14, 8:30 — Real-time AI support for endovascular therapy — a paradigm shift toward the medicine of the future — https://www.congre.co.jp/jsnet2025/ A total of thirteen AI-related presentations from the Company were given.